Microorganisms · 2026
Environmental Investigations of Travel-Associated Legionnaires' Disease Cases: Timeliness, Microbiological Findings, and Public Health Response.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Papadakis Antonios, Koufakis Eleftherios, Chochlakis Dimosthenis, Psaroulaki Anna
Аннотация
In Europe, travel-associated Legionnaires' disease (TALD) cases require timely environmental investigations to support risk assessment, rapid control measures, and prompt reporting of investigation findings to the European Legionnaires' Disease Surveillance Network (ELDSNet). This study evaluated TALD-related environmental investigations conducted during 2025 and early 2026 in Crete, Greece, following notifications through ELDSNet. Overall, 30 notifications corresponded to 24 unique confirmed TALD cases with illness onset in 2025 and 24 implicated hotels, with some cases involving stays in multiple hotels and Regional Units and clusters identified in some implicated hotels. The investigation framework combined microbiological, physicochemical, and operational data, focusing on delays from symptom onset, notification, sampling, and laboratory reporting. Overall, 516 environmental samples were collected, of which 503 yielded valid analytical results. Among the 503 samples analyzed, Legionella spp. were detected at ≥50 colony-forming units per liter (CFU/L) in 127 samples (25.25%). This included 123 samples positive for L. pneumophila (24.45%), of which 31 were serogroup 1 (6.16%). Concentrations exceeding the 1000 CFU/L threshold were recorded in 53 samples (10.54%). Operational indicators varied, with median values of 31.0 days for reporting delay (RD), 14.5 days from notification to first sampling (TTF), 47.5 days from symptom onset to first sampling (TDS), and 67.0 days from symptom onset to first laboratory result (OELR). The findings underscore the necessity to document response delays, enhance inspector capacity and cross-regional coordination, and integrate microbiological results with operational indicators. This integration is crucial for facilitating earlier environmental risk assessments, expediting reporting, and implementing more effective TALD public health interventions.